University of Minnesota. Driven to Discover.
The review recommends investment in innovative manufacturing and greater FDA authority.
IQVIA's 5-year forecast estimates the pandemic's effects on the global pharmaceutical market.
Experts outline pre-COVID-19 problems and spell out key steps to take.
Researchers estimate Canada's potential demand for tocilizumab, a potential COVID-19 drug.
Vaccines are just one of many COVID-disrupted services, a recent survey notes.
Should studies show COVID-19 effectiveness, fluvoxamine's supply chain looks resilient, an expert says.
In spite of an increase in days of supply, data still show discontinuation of some drugs.
Operation Warp Speed halted Tepezza manufacturing, but supplies of the drug will return this month.
The WHO and its partners will assess shortages of raw materials like plastic, glass, stoppers, and vials.
GAO emphasizes addressing the backlog, pre-announced inspections, and alternative approaches.
Braga JU, Araaujo RS, de Souza AS. The shortage of benzathine penicillin and its impact on congenital syphilis incidence: an ecologic study in the city of Rio de Janeiro. Clin Infect Dis 2020 (published online Nov 17)
Get CIDRAP news and other free newsletters.
Sign up now»
Grant support for RDS provided by
Unrestricted financial support provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2021 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.